158 related articles for article (PubMed ID: 38100630)
1. Boosting weight loss after conversional Roux-en-Y Gastric Bypass with liraglutide and placebo use. A double-blind-randomized controlled trial.
Hany M; Torensma B; Ibrahim M; Zidan A; Agayby ASS; Abdelkhalek MH; El Sayed I
Int J Surg; 2024 Mar; 110(3):1546-1555. PubMed ID: 38100630
[TBL] [Abstract][Full Text] [Related]
2. A commentary on 'Boosting weight loss after conversional Roux-en-Y Gastric Bypass with liraglutide and placebo use. A double-blind-randomized controlled trial'.
Han T; Wang T
Int J Surg; 2024 Apr; 110(4):2483-2484. PubMed ID: 38241302
[No Abstract] [Full Text] [Related]
3. Outcomes of primary versus conversional Roux-En-Y gastric bypass after laparoscopic sleeve gastrectomy: a retrospective propensity score-matched cohort study.
Hany M; Torensma B; Zidan A; Ibrahim M; Abouelnasr AA; Agayby ASS; Sayed IE
BMC Surg; 2024 Mar; 24(1):84. PubMed ID: 38448841
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial.
Mok J; Adeleke MO; Brown A; Magee CG; Firman C; Makahamadze C; Jassil FC; Marvasti P; Carnemolla A; Devalia K; Fakih N; Elkalaawy M; Pucci A; Jenkinson A; Adamo M; Omar RZ; Batterham RL; Makaronidis J
JAMA Surg; 2023 Oct; 158(10):1003-1011. PubMed ID: 37494014
[TBL] [Abstract][Full Text] [Related]
5. One Anastomosis Gastric Bypass versus Roux-en-Y Gastric Bypass: A Randomized Prospective Trial.
Karagul S; Senol S; Karakose O; Uzunoglu K; Kayaalp C
Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399543
[No Abstract] [Full Text] [Related]
6. Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Angelidi AM; Kokkinos A; Sanoudou D; Connelly MA; Alexandrou A; Mingrone G; Mantzoros CS
Metabolism; 2023 Jan; 138():155346. PubMed ID: 36375643
[TBL] [Abstract][Full Text] [Related]
7. Revisional One-Step Bariatric Surgical Techniques After Unsuccessful Laparoscopic Gastric Band: A Retrospective Cohort Study with 2-Year Follow-up.
Hany M; Zidan A; Ibrahim M; Sabry A; Agayby ASS; Mourad M; Torensma B
Obes Surg; 2024 Mar; 34(3):814-829. PubMed ID: 38231451
[TBL] [Abstract][Full Text] [Related]
8. Variation in HbA1c in Patients with Obesity and type 2 Diabetes Mellitus 12 months after Laparoscopic One-Anastomosis Gastric Bypass and Laparoscopic Roux-en-Y Gastric Bypass: a Retrospective Matched Cohort Study.
van Rijswijk AS; Meijnikman AS; Mikdad S; Hutten BA; van der Peet DL; van de Laar AW; Gerdes VEA; de Brauw M
Obes Surg; 2024 Mar; 34(3):940-946. PubMed ID: 38321253
[TBL] [Abstract][Full Text] [Related]
9. Liraglutide Augments Weight Loss After Laparoscopic Sleeve Gastrectomy: a Randomised, Double-Blind, Placebo-Control Study.
Thakur U; Bhansali A; Gupta R; Rastogi A
Obes Surg; 2021 Jan; 31(1):84-92. PubMed ID: 32656729
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial.
Miras AD; Pérez-Pevida B; Aldhwayan M; Kamocka A; McGlone ER; Al-Najim W; Chahal H; Batterham RL; McGowan B; Khan O; Greener V; Ahmed AR; Petrie A; Scholtz S; Bloom SR; Tan TM
Lancet Diabetes Endocrinol; 2019 Jul; 7(7):549-559. PubMed ID: 31174993
[TBL] [Abstract][Full Text] [Related]
12. Total Weight Loss as the Outcome Measure of Choice After Roux-en-Y Gastric Bypass.
Corcelles R; Boules M; Froylich D; Hag A; Daigle CR; Aminian A; Brethauer SA; Burguera B; Schauer PR
Obes Surg; 2016 Aug; 26(8):1794-8. PubMed ID: 26803753
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of 1-year outcomes between Roux-en-Y gastric bypass and sleeve gastrectomy with Roux-en-Y duodenojejunal bypass in the patients of obesity with type 2 diabetes mellitus].
Liang H; Si YM; Lin SB; Shen JJ; Guan W
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Nov; 26(11):1051-1057. PubMed ID: 37974350
[No Abstract] [Full Text] [Related]
14. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial.
Halawi H; Khemani D; Eckert D; O'Neill J; Kadouh H; Grothe K; Clark MM; Burton DD; Vella A; Acosta A; Zinsmeister AR; Camilleri M
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):890-899. PubMed ID: 28958851
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
[TBL] [Abstract][Full Text] [Related]
16. Conversion to Roux-en-Y gastric bypass versus one-anastomosis gastric bypass after a failed primary gastric band: a matched nationwide study.
Akpinar EO; Nienhuijs SW; Liem RSL; Greve JWM; Marang-van de Mheen PJ;
Surg Obes Relat Dis; 2022 Jul; 18(7):948-956. PubMed ID: 35659796
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery.
Muratori F; Vignati F; Di Sacco G; Gavazzi L; Pellegrino D; Del Prete M
Eat Weight Disord; 2022 Oct; 27(7):2775-2781. PubMed ID: 35763245
[TBL] [Abstract][Full Text] [Related]
18. Primary Roux-en-Y Gastric Bypass Results in Greater Weight Loss at 15-Year Follow-Up Compared with Secondary Roux-en-Y Gastric Bypass After Failure of Gastric Band or Mason McLean Vertical Gastroplasty.
Etienne JH; Petrucciani N; Goetschy M; Gugenheim J; Schneck AS; Iannelli A
Obes Surg; 2020 Oct; 30(10):3655-3668. PubMed ID: 32488745
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
O'Neil PM; Birkenfeld AL; McGowan B; Mosenzon O; Pedersen SD; Wharton S; Carson CG; Jepsen CH; Kabisch M; Wilding JPH
Lancet; 2018 Aug; 392(10148):637-649. PubMed ID: 30122305
[TBL] [Abstract][Full Text] [Related]
20. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
le Roux CW; Astrup A; Fujioka K; Greenway F; Lau DCW; Van Gaal L; Ortiz RV; Wilding JPH; Skjøth TV; Manning LS; Pi-Sunyer X;
Lancet; 2017 Apr; 389(10077):1399-1409. PubMed ID: 28237263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
